After more than five years at Microsoft, I went back to zero in 2026, one more time.
I am building Ayomic, an applied research lab for bioprocesses. A bioprocess puts living cells to work, to make things we need, like medicines and food. Something that works in a small flask in a lab can behave very differently in a tank the size of a room. Getting it right at that size takes trial after trial in the real world, and every trial is slow and costly.
We believe simulation is how AI will help solve the biggest problems the world faces. The real world is costly and difficult to experiment in. A good simulation lets you try many ideas quickly and safely, and take only the best ones into the real world.
So we are building a simulation-first platform, and we are starting with one hard problem: scaling bioprocesses, from the lab to the factory.
There is a quiet circle in this for me. I became a chemical engineer because that was the only seat open to me, while my heart was with computers. Ayomic is where the two finally meet.
This chapter has no ending yet. If you work on bioprocesses or simulation, and this problem is yours too, I would love to hear from you.